10 U.S. lawmakers have disclosed 19 Humana Inc. trades under the STOCK Act — 15 buys and 4 sells between 2015 and 2026. Congress has been net buyers of HUM, and their disclosed buys are up 43.8% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of HUM, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed HUM buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-27 | Alan Armstrong | BUY | $1K–$15K | $169.09 | $384.97 2026-08-13 | +127.7% |
| 2025-10-27 | Michael T. McCaul | SELL | $1K–$15K | $292.34 | $384.97 2026-08-13 | -31.7% exit |
| 2025-09-25 | Lisa McClain | BUY | $1K–$15K | $254.43 | $384.97 2026-08-13 | +51.3% |
| 2025-02-26 | Gilbert Cisneros | BUY | $1K–$15K | $255.07 | $384.97 2026-08-13 | +50.9% |
| 2024-04-02 | Byron Donalds | BUY | $1K–$15K | $304.33 | $384.97 2026-08-13 | +26.5% |
| 2024-03-27 | Byron Donalds | SELL | $1K–$15K | $349.50 | $384.97 2026-08-13 | -31.1% rt |
| 2024-02-22 | Byron Donalds | BUY | $1K–$15K | $368.08 | $384.97 2026-08-13 | +4.6% |
| 2024-02-02 | Byron Donalds | BUY | $1K–$15K | $378.87 | $384.97 2026-08-13 | +1.6% |
| 2023-02-24 | Byron Donalds | BUY | $1K–$15K | $507.42 | $384.97 2026-08-13 | -24.1% |
| 2020-10-29 | John A. Yarmuth | BUY | $1K–$15K | $396.75 | $384.97 2026-08-13 | -3.0% |
| 2018-12-17 | Virginia Foxx | SELL | $50K–$100K | $303.22 | $384.97 2026-08-13 | +12.3% rt |
| 2018-05-04 | James B. Renacci | BUY | $1K–$15K | $287.39 | $384.97 2026-08-13 | +34.0% |
| 2018-03-19 | Virginia Foxx | BUY | $15K–$50K | $269.98 | $384.97 2026-08-13 | +42.6% |
| 2016-04-13 | James B. Renacci | BUY | $1K–$15K | $169.96 | $384.97 2026-08-13 | +126.5% |
| 2015-09-28 | James B. Renacci | BUY | $1K–$15K | $174.16 | $384.97 2026-08-13 | +121.0% |
| 2015-07-01 | Kenny Marchant | BUY | $1K–$15K | $193.14 | $384.97 2026-08-13 | +99.3% |
| 2015-05-13 | Diane Black | BUY | $1K–$15K | $173.50 | $384.97 2026-08-13 | +121.9% |
| 2015-05-07 | Diane Black | SELL | $1K–$15K | $164.54 | $384.97 2026-08-13 | -134.0% exit |
| 2015-05-07 | Diane Black | BUY | $1K–$15K | $164.54 | $384.97 2026-08-13 | +134.0% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
10 members of the U.S. House and Senate have disclosed Humana Inc. transactions under the STOCK Act — 15 purchases and 4 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a HUM purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed HUM buys are up 43.8% versus the latest close of $384.97. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded HUM and how it performed.